All NNECOS active and associate members in good standing are invited to participate in the 2019  NNECOS Board of Directors election.

Online voting in the 2019 NNECOS Board of Directors Election is open through 11:00pm September 24, 2019. The election requires a minimum of 10 percent of the voting eligible members to participate to be valid. Eligible voters were sent an email with voting instructions and a personalized link from on September 3rd. Please contact NNECOS at if you did not receive this email. Results will be announced in late September.

Each director is elected for a term of three (3) years on a rotating basis. 

Candidates Eligible for Election

* indicates current board member

Active Associate Member Candidate

NNECOS Board Service

Leadership Positions
  • At Large Associate Executive Committee Member 2017-present
  • NAHPAC Co-Chair2017-present
  • OCN Review Nurse Planner 2016-present
  • Spring & Annual Meeting Nurse Planner 2015-present
  • 2018 NNECOS Distinguished Service Awardee

Elizabeth B. McGrath DNP, AGACNP-BC, AOCNP, ACHPN*
Advanced Practice Nurse, Dartmouth Hitchcock Medical Center

Elizabeth received her DNP in 2015 at Northeastern University. Elizabeth is an advanced practice nurse currently employed at Dartmouth Hitchcock as a nurse practitioner in the Gastrointestinal Program in the Norris Cotton Cancer Center. She is Chair of the NCCC Survivorship Steering Committee and leads the Distress Subcommittee. Elizabeth has over thirty year’s oncology experience and has worked in a variety of practice settings in Vermont and New Hampshire, including radiation therapy and medical oncology. 

Elizabeth has extensive clinical expertise and holds certification as an Adult Geriatric Acute Care Nurse Practitioner, as well as an Advanced Oncology Nurse Practitioner and an Advanced Certified Hospice and Palliative Care Nurse. Her professional experiences also include more than twenty years of management experience which has provided her with knowledge of the financial and regulatory issues facing oncology practices today. Through active membership to organizations such as NNECOS as well as the ANA, ONS, HPNA, ASTRO, and ASCO, Elizabeth has been involved in advocacy issues and serves on the Board of Directors for the New Hampshire Comprehensive Cancer Collaborative. Elizabeth is an active member of the NNECOS Nursing and Allied Health Professional Advisory Committee, has led the OCN review course for NNECOS since 2015, and  serves as the nurse planner for our educational meetings. 

Elizabeth was appointed to the NNECOS Board of Directors in January of 2015, and appointed as the first At Large Associate Executive Committee Member in 2017. Elizabeth is a 2018 recipient of a NNECOS Distinguished Service Award.

Active Physician Member Candidates

NNECOS Board Service

Leadership Positions:
  • President 2016-2017
  • Patient Access Work Group Chair
  • Abstract Review Committee

John M. Hill, Jr., MD
​Director, Allogeneic Transplant and Cellular Therapy Program, Section of Hematology, Dartmouth-Hitchcock Medical Center (DHMC)
Associate Professor of Medicine, Geisel School of Medicine at Dartmouth

​Dr. Hill received his BA from Princeton University and his MD from the University of Connecticut School of Medicine. He completed his Internal Medicine Internship and Residency at the National Naval Medical Center, Bethesda, MD. During Hematology/Oncology Fellowship at the Navy/National Cancer Institute (NCI), he also undertook subspecialty training in Bone Marrow Transplantation at the Fred Hutchinson Cancer Research Center, Seattle, WA. He then served as Transplant and Hematology/Oncology Attending Physician at the National Naval Medical Center and Walter Reed Army Medical Center before joining the Staff of Norris Cotton Cancer Center, DHMC, in 2003. Since assuming his position at Dartmouth, Dr. Hill has strived to expand the Allogeneic BMT Program while continuing to optimize outcomes for an increasing population of older and more diverse patients with hematologic malignancies. His efforts include the early initiation of non-myeloablative, reduced intensity and unrelated transplants, then haplo-identical transplants, along with FACT (Foundation for the Accreditation of Cellular Therapy) accreditation and program participation in the Radiation Injury Treatment Network (RITN) for the past several years.

Dr. Hill is particularly interested in the use of adoptive immunotherapy for the treatment of patients with hematologic malignancies and in novel approaches toward minimizing morbidity and mortality and optimizing functional status following allogeneic stem cell transplant. This includes early detection of and intervention for graft rejection, graft-versus- host disease (GVHD), cardio-pulmonary sequelae and relapse of malignancy. He is currently PI on trials to improve management of both acute and chronic GVHD, along with a trial assessing the predictive potential of early chimerism analysis, for which he is the recipient of a NNECOS grant. Most recently, he has played an instrumental role in bringing Chimeric Antigen Receptor (CAR) T-Cell Therapy onboard at DHMC, expected to be implemented in September 2019.

An additional focus of Dr. Hill’s has been the teaching and mentoring of medical students, residents and fellows, with projects that have included poster and podium presentations at numerous NNECOS Annual Meetings and poster discussions at both the American Society of Hematology and Transplant and Cellular Therapy national meetings. In this regard, the unique role that NNECOS plays in enhancing the education of our young clinicians has been a priority of his, along with the timely procurement of affordable anti-cancer agents for patients in the tri-state community. Dr. Hill was appointed to the NNECOS Board of Directors in October of 2014 and served as NNECOS President during 2016-2017.

NNECOS Board Service

Leadership Positions:
  • President 2007-2008
  • Education Task Force Chair
  • Abstract Review Committee Chair
  • Research Review Committee
  • 2018 NNECOS Distinguished Service Awardee

Kenneth R. Meehan, MD*
Professor of Medicine for the Section of Hematology/Oncology at the Giesel School of Medicine at Dartmouth 
Director, Bone Marrow Transplant Program

Dr. Kenneth Meehan received his BS in 1981 from Fairfield University, and his MD in 1986 from Georgetown University where he also completed an internship/residency in 1989. In 1992 Dr. Meehan completed a Hematology/Oncology Fellowship at the Dartmouth Hitchcock Medical Center. From 1992 to 1994 Dr. Meehan was a Research Fellow and Associate Clinical Staff member for the Section of Hematology/Oncology at the DHMC. In 1994 he joined the faculty at the Georgetown University Medical Center and in held a variety of positions there including Director, Bone Marrow Transplantation Clinic and Director, Adult Bone Marrow Transplantation Research Laboratory, and Director, National Marrow Donor Program (Transplant Center). 

In July 2001 Dr. Meehan returned to the DHMC as Associate Professor of Medicine for the Section of Hematology/Oncology, Director, Bone Marrow Transplant Program, and as Associate Section Chief, Hematology/Oncology.

Dr. Meehan is a past NNECOS president, having been responsible for bringing the abstract program to our annual meeting. Dr. Meehan currently serves as chair of the Education Task Force responsible for the Educational Program Grants as well as the Educational Video Library. Dr. Meehan joined the NNECOS Board of Directors in October of 2004. 


NNECOS Active Physician Member

NNECOS Involvement

  • Abstract Poster Presenter - 2008
  • Abstract Podium Presentation - 2009
  • NNECOS Fellows Breakfast Host - 2018
Cocav Rauwerdink, MD
Medical Oncologist/Hematologist
Massachusetts General Hospital at Exeter Hospital

My New England journey began in 2003 with a subinternship at Dartmouth. When I stepped off the plane from Southern California, my first thought was that the air smelled much better in New Hampshire. I spent residency and fellowship at Dartmouth Hitchcock Medical Center and grew to love understated and gritty New Englanders.

My first job after fellowship was in Bone Marrow Transplant at Dartmouth. I then joined Lahey Health to start a new oncology clinic from scratch in Salem, NH in association with Parkland Medical Center. There I served as the Chairman of the IRB. In 2017, I joined Massachusetts General Physicians Organization to practice at Exeter Hospital in Exeter, NH. About half of my practice is Hematology, and I am the designated oncologist for the Head and Neck Cancer and the Genitourinary Multidisciplinary Groups. I enroll patients on clinical trials at our facility. In addition to clinical duties, I have also served on the Cancer Center redesign committee and am the physician leader of the Survivorship Care Team.

I first joined NNECOS as a fellow in 2007 and presented my research several times. I have also participated in activities for fellows through NNECOS. In 2008, I began a long list of talks to physicians, nurses, and community members on Hematology and Oncology topics at hospitals in New Hampshire, Vermont, Maine, and Massachusetts and have twice spoken at King Edward VII Hospital in Bermuda.

Moving to New England has been a wonderful adventure for me so far, and I intend to never leave. I look forward to many more years of providing not only sound hematologic and oncologic care for gritty New Englanders but also educating them, bringing them cutting edge care through research trials, and helping to cultivate a new generation of Hematologists and Oncologists.

NNECOS Board Service

Leadership Positions:
  • President 2017-2018
  • Research Review Committee
  • Abstract Review Committee
  • ASCO State Affiliate Council Representative 2018-present

Christian A. Thomas, MD*
Director of Clinical Research, New England Cancer Specialists

Dr. Thomas was born and raised near Frankfurt, Germany. In 1990 after graduating from Goethe University Medical School in Germany, he came to Columbia University in New York City to work on a research project and then stayed to complete his residency in Internal Medicine and a Fellowship in Hematology and Oncology. Dr. Thomas met his wife, Elizabeth, in New York and after completing his fellowship they decided they were ready to leave the city for the fresh air and mountains of Vermont. They moved in 1999.

He became a partner in a hematology/oncology practice in Colchester and he and his family stayed to enjoy the beauty of the Green Mountain State for 13 years. In 2012 he was delighted to have the opportunity to come to Maine to work at New England Cancer Specialists as a physician and the Director of Clinical Research. His clinical focus is on thoracic cancers (lung cancer, esophageal cancer) as well as GU cancers (prostate, testicular, bladder and kidney cancers).

The immediate past president of NNECOS, Dr. Thomas also represents NNECOS on the State Affiliate Council and serves as an advisor to the American Society of Clinical Oncology and CMS/Medicare. He lives in Portland with his wife, a photographer, his three daughters and two dogs. In his free time he enjoys rowing, cooking, playing squash and getting to know the great state of Maine.

NNECOS Board Service

Leadership Positions:
  • President 2018-present
  • Treasurer 2014-2016
  • Finance Committee
  • Executive Committee
Paul Unger, MD - President*
Medical Oncologist, Champlain Valley Hematology Oncology 
Clinical Associate Professor of Medicine, the University of Vermont Medical Center

Dr. Paul Unger has practiced hematology and oncology in Vermont since 1994. He is a founding partner with Champlain Valley Hematology Oncology, a community-based oncology practice in the Burlington, Vermont area.

Dr. Unger completed his undergraduate studies at Wesleyan University. He went on to medical school at Harvard Medical school and then did his internal medicine training at Cornell/New York Hospital Medical Center and Memorial Sloan-Kettering Cancer Center. Fellowship training in Hematology and Oncology was at the Dana-Farber Cancer Institute and Brigham and Women’s Hospital in Boston followed by two years on staff at Memorial Sloan-Kettering Cancer Center before his move to Vermont.

As a Clinical Associate Professor of Medicine at the University of Vermont Medical Center, he is a cofounder of the Breast Care Center and the Stem Cell Transplant Program and has been active in clinical research through the Vermont Cancer Center enrolling patients on clinical trials, serving on the cancer committee of the hospital, and has served as the hospital medical staff president in the past and current chair of the Credentials Committee of the Medical Staff.

Dr. Unger has been active in the American Society of Clinical Oncology as a member of the ASCO Supportive Care Guideline Advisory Group and the QOPI Steering Committee, and ASH as a member of the ASH Practice Partnership. He has been actively involved in the Northern New England Clinical Oncology society over the last few years, most recently serving on the board of directors since 2013, previous treasurer and this year as President of NNECOS.

Northern New England Clinical Oncology Society
P.O. Box 643
Sandown, NH 03873-0643
Telephone (603) 887-1948

This website brought to you by:

Powered by Wild Apricot Membership Software